Literature DB >> 8601641

Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity.

P C Swanson1, R L Yung, N B Blatt, M A Eagan, J M Norris, B C Richardson, K J Johnson, G D Glick.   

Abstract

Although anti-DNA autoantibodies are an important hallmark of lupus, the relationships among anti-DNA structure, reactivity, and pathogenicity have not been fully elucidated. To further investigate these relationships, we compare the variable genes and primary structure of eight anti-DNA mAbs previously obtained from an MRL/MpJ-lpr/lpr mouse along with the ability of three representative mAbs to induce nephritis in nonautoimmune mice using established adoptive transfer protocols. One monospecific anti-single-stranded (ss) DNA (11F8) induces severe diffuse proliferative glomerulonephritis in nonautoimmune mice whereas another anti-ssDNA with apparently similar in vitro binding properties (9F11) and an anti-double-stranded DNA (4B2) are essentially benign. These results establish a murine model of anti-DNA-induced glomerular injury resembling the severe nephritis seen in lupus patients and provide direct evidence that anti-ssDNA can be more pathogenic than anti-double-stranded DNA. In vitro binding experiments using both protein-DNA complexes and naive kidney tissue indicate that glomerular localization of 11F8 may occur by recognition of a planted antigen in vivo. Binding to this antigen is DNase sensitive which suggests that DNA or a DNA-containing molecule is being recognized.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601641      PMCID: PMC507240          DOI: 10.1172/JCI118602

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  81 in total

1.  A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis.

Authors:  R A Lake; A Morgan; B Henderson; N A Staines
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

Review 2.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

3.  The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice.

Authors:  H Dang; R J Harbeck
Journal:  Clin Immunol Immunopathol       Date:  1984-02

4.  Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins.

Authors:  M Potter; J B Newell; S Rudikoff; E Haber
Journal:  Mol Immunol       Date:  1982-12       Impact factor: 4.407

5.  Monoclonal antibodies showing sequence specificity in their interaction with single-stranded DNAs.

Authors:  J S Lee; J R Lewis; A R Morgan; T R Mosmann; B Singh
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

6.  The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes.

Authors:  P H Brodeur; R Riblet
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

7.  Complement activation by antibodies to Sm in systemic lupus erythematosus.

Authors:  U K Sabharwal; S Fong; S Hoch; R D Cook; J H Vaughan; J G Curd
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  In vivo clearance and tissue uptake of an anti-DNA monoclonal antibody and its complexes with DNA.

Authors:  E Ben Chetrit; E H Dunsky; S Wollner; D Eilat
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Specificity of autoimmune monoclonal Fab fragments binding to single-stranded deoxyribonucleic acid.

Authors:  J S Lee; D F Dombroski; T R Mosmann
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

10.  Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments.

Authors:  Y Kurosawa; S Tonegawa
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  8 in total

1.  Specific recognition of a dsDNA sequence motif by an immunoglobulin VH homodimer.

Authors:  Hulin Jin; Jorge Sepúlveda; Oscar R Burrone
Journal:  Protein Sci       Date:  2004-12       Impact factor: 6.725

2.  Impact of DNA hairpin folding energetics on antibody-ssDNA association.

Authors:  Zhonghui Ou; Christopher A Bottoms; Michael T Henzl; John J Tanner
Journal:  J Mol Biol       Date:  2007-10-03       Impact factor: 5.469

3.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

4.  Bispecific abs against modified protein and DNA with oxidized lipids.

Authors:  Mitsugu Akagawa; Sohei Ito; Kazuyo Toyoda; Yoshihisa Ishii; Emi Tatsuda; Takahiro Shibata; Satoru Yamaguchi; Yoshichika Kawai; Kousuke Ishino; Yusuke Kishi; Takahiro Adachi; Takeshi Tsubata; Yoshinari Takasaki; Nobutaka Hattori; Tsukasa Matsuda; Koji Uchida
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

5.  Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus.

Authors:  T Dörner; S J Foster; N L Farner; P E Lipsky
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.

Authors:  L Budhai; K Oh; A Davidson
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

7.  Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination.

Authors:  L Spatz; V Saenko; A Iliev; L Jones; L Geskin; B Diamond
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice.

Authors:  Zhiyan Liang; Chun Xie; Cui Chen; Desi Kreska; Kelvin Hsu; Liunan Li; Xin J Zhou; Chandra Mohan
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.